Search

everythinglearnresearchcommunity

for

Search:↓

PCOS may increase the risk of certain cancers.

PCOS is linked to a higher risk of endometrial cancer but not ovarian or breast cancer, and more research is needed on its role in cancer development and treatment effects.

Stem cells can improve wound healing, reduce scars, promote hair growth, rejuvenate skin, and enhance fat grafts in plastic surgery, but there are still some concerns.

The exact identity of skin stem cells and how skin cells differentiate is not fully known.

People with atopic dermatitis have more CD4+ T cells that respond to a certain bacterial lipid, which may play a role in the skin condition's inflammation.

Cancer rates are increasing in developed countries, with estrogen, aging, low vitamin D3, and HPV infection as common causes.

Understanding phenotypic plasticity is crucial for developing effective cancer therapies.

Androgens may cause hair loss by increasing TGF-beta1 from scalp cells, which inhibits hair cell growth.

Androgens block hair growth by disrupting cell signals; targeting GSK-3 may help treat hair loss.

Dermal Papilla cells are a promising tool for evaluating hair growth treatments.

Androgens slow hair growth by altering Wnt signaling in balding cells.

The document concludes that targeting the androgen receptor may be a promising breast cancer treatment, especially for certain types.

High levels of testosterone and 5α-DHT can lead to cell death in cells important for hair growth.

Sorafenib helps some advanced cancers alone or with other treatments, but not all, and research continues to improve its use.

Beard and scalp hair cells have different gene expressions, which may affect beard growth characteristics.

Androgen receptor signaling causes early aging of cells important for hair growth by damaging their DNA.

Blocking DHT production more strongly may help control advanced prostate cancer and improve quality of life.

PlncRNA-1 helps hair follicle stem cells grow and develop by controlling a specific cell signaling pathway.

The study found that women with hyperandrogenic PCOS have higher levels of AKT1 and AKT2 proteins in their cells, which may lead to cell dysfunction.

Baicalin helps hair growth by activating specific cell signals and pathways.

The medications 5α-reductase inhibitors and spironolactone are generally safe for breast cancer patients on endocrine therapies and do not significantly increase breast cancer risk.

DHT affects hair follicle cells by changing microRNA levels, leading to less cell growth and more cell death.

Men taking 5-alpha-reductase inhibitors before or after bladder cancer diagnosis had a lower risk of dying from the disease.

Scientists have created a method to deliver specific cells that can regenerate hair follicles, potentially offering a new treatment for hair loss.

Dihydrotestosterone (DHT) doesn't affect rat skin cell growth, but it does change cell cycle, protein levels, and other cell functions, potentially shortening hair growth cycle.

TGF-β1 increases androgen receptor activity in hair loss, but Hic-5/ARA55 can counter this effect.

Anti-cancer treatments can cause reversible hair loss, skin sensitivity, pigmentation changes, nail damage, and skin reactions, with a need for more research on managing these side effects.

UVB radiation changes the levels of certain microRNAs in skin cells, which may affect cell survival and hair growth.

The document suggests that blocking sweat glands with antiperspirants might allow skin-generated hormones to be absorbed, possibly increasing breast and prostate cancer risk.

Estrogen increases blood vessel growth factor production, while testosterone blocks this increase.